0.7225
-0.007 (-0.96%)
-0.007 (-0.96%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cyclacel Pharmaceuticals Inc | CYCC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.016 | 2.24% | 0.7295 | 0.71 | 0.7349 | 0.72 | 0.7135 | 18:00:01 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.71 | 0.75 | 0.04 | 5.33% | - | 1 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 128 | 44,410 | $ 0.7170207 | $ 31,843 | 265,936 | 0.2813 - 1.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:01:06 | 45 | $ 0.7225 | USD |
Cyclacel Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 12.55M | 17.20M | $ -7.29M | -0.63 | - | 16.20M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 6.00 | 5.80% |
Cyclacel Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYCC Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.7234 | 0.75 | 0.71 | 0.7347633 | 59,373 | 0.0061 | 0.84% |
| 1 Month | 0.81 | 0.8999 | 0.65 | 0.729657 | 118,314 | -0.0805 | -9.94% |
| 3 Months | 0.533 | 0.979869 | 0.50 | 0.7264771 | 276,698 | 0.1965 | 36.87% |
| 6 Months | 0.4566 | 0.979869 | 0.32 | 0.6548387 | 160,201 | 0.2729 | 59.77% |
| 1 Year | 0.8041 | 1.40 | 0.2813 | 0.780027 | 415,450 | -0.0746 | -9.28% |
| 3 Years | 5.40 | 10.90 | 0.2813 | 2.40 | 366,834 | -4.67 | -86.49% |
| 5 Years | 0.80 | 10.90 | 0.2813 | 2.41 | 354,475 | -0.0705 | -8.81% |
Cyclacel Pharmaceuticals Description
| Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include CYC065 CDK inhibitor, Sapacitabine and seliciclib, CYC682, CYC140 PLK inhibitor, and CYC202. The company earns the majority of its revenue from the United Kingdom. |
